Interview: Hemogenyx

The Hemogenyx breakthrough heralds the double whammy of the end of chemotherapy and the need for bone marrow transplants to treat blood diseases, as well as a new investment situation.

Dr. Vladislav Sandler is the founder and CEO of Hemogenyx and Adrian Beestan, Director at Hemogenyx Pharmaceuticals talk to host Zak Mir about the company’s mission.

 

Smith & Nephew: “UFO” Alert

Now and again there is chatter regarding a perennial takeover target. The one in focus at the moment is Smith & Nephew. By rights the group should have allowed itself to be taken over years ago. But instead the management seems to have preferred to soldier on, attempting to extract shareholder value. Good luck with that.

One could describe the present position of the surgical devices group as it being something of an Unidentified Flying Object, with no real story or substance to the talk surrounding it.

sn

That said, the daily chart appears very strong, a point witnessed by the April / May / June and July gaps to the upside. The latest recovery of the 50 day moving average at 1,353p is encouraging, with a weekly close above this number underpinning the idea that the next time the shares touch 1,400p they could keep going. This is on the basis that since April the appearance of the chart has been very constructive.

Disclaimer:

Zakmir.com is a purely journalistic website – Zak Mir is a member of the NUJ. There is no intention here of providing financial advice and absolutely no interest in speculating in the companies mentioned. It is  recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.

Yoox Net-a-Porter: Update

yoox

Shares in Yoox Net-a-Porter have continued to rally after a couple of articles written highlighting its M&A credentials. The latest entity to get on the bandwagon is HSBC, tipping the stock as a potential takeover target – slightly behind the curve one could say.

Interestingly enough, the present charting trajectory of the shares within a rising trend channel which can be drawn in on the daily chart from as long ago as June last year is implying a €40 target, well above the €37 rumoured price of any deal.

ynap

Disclaimer:

Zakmir.com is a purely journalistic website – Zak Mir is a member of the NUJ. There is no intention here of providing financial advice and absolutely no interest in speculating in the companies mentioned. It is  recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.

 

Refresco: Likely To Reject Latest Offer, Aim For €22

Refresco has been on the runway as far as intense M&A speculation in recent days, with hedgies and others getting what they wanted today with the €1.6bn offer from PAI Partners. This according to sources is likely to be rejected, in similar fashion to the offer from Cott Corp in July. However, the rumour is that a higher bid at €22 a share (versus the equivalent of €19.75 on the table now) could eventually be forthcoming in this bidding war situation. This may be worth waiting for as far as fans of the Dutch juice bottling group is concerned.

Disclaimer:

Zakmir.com is a purely journalistic website – Zak Mir is a member of the NUJ. There is no intention here of providing financial advice and absolutely no interest in speculating in the companies mentioned. It is  recommended you seek an independent professional opinion before deciding whether or not to take any action with regard to anything written here.

POW: Airdrop Launch of the “First Global Currency”

PowlogoIn today’s podcast, Simon Wajcenberg, Founder at Powtoken.com describes tomorrow’s momentous airdrop launch via Facebook of the world’s first global currency.  The giveaway is apparently enough for every internet user on the planet. But is it all too good to be true?